Novan, Inc. (NOVN) News

Novan, Inc. (NOVN): $2.65

0.11 (+4.33%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter NOVN News Items

NOVN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

NOVN News Highlights

  • NOVN's 30 day story count now stands at 5.
  • Over the past 12 days, the trend for NOVN's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • DRUG, GEL and KIM are the most mentioned tickers in articles about NOVN.

Latest NOVN News From Around the Web

Below are the latest news stories about Novan Inc that investors may wish to consider to help them evaluate NOVN as an investment opportunity.

Novan GAAP EPS of -$1.74, revenue of $2.96M

Novan press release (NASDAQ:NOVN): Q4 GAAP EPS of -$1.74. Revenue of $2.96M (-39.8% Y/Y). The Company reported a cash and cash equivalents balance of $47.1 million as of December 31, 2021....

Seeking Alpha | February 22, 2022

Novan, Inc. (NOVN) CEO Paula Brown Stafford On Q4 2021 Results - Earnings Call Transcript

Novan, Inc. (NOVN) Q4 Earnings Conference Call February 22, 2022 8:30 AM ET Company Participants Paula Brown Stafford - Chairman and Chief Executive Officer John M. Gay - Chief Financial Officer Conference Call Participants Jonathan Aschoff - Roth Capital Jennifer Kim - Cantor Fitzgerald Oren Livnat - HC Wainwright John...

SA Transcripts on Seeking Alpha | February 22, 2022

Novan Reports Full Year 2021 Financial Results and Provides Corporate Update

– First New Drug Application (NDA) submission targeted in Q4 2022 for lead program SB206 (berdazimer gel 10.3%) for molluscum contagiosum – – Ongoing advancement of priority development pipeline assets SB019, for the treatment of SARS-CoV-2, toward a Phase 1 study in 2022, and SB204, for the treatment of acne vulgaris, toward a registrational Phase 3 study in 2023 – – Company to host update conference call and webcast today at 8:30 a.m. ET – DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Novan,

Yahoo | February 22, 2022

Novan to Report Full Year 2021 Financial Results on February 22, 2022

DURHAM, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2021 financial results on Tuesday, February 22nd. Novan management will host a conference call and live audio webcast to discuss the operational and financial results at 8:30 a.m. ET that same day. The call will be led by Paula Brown Stafford, President and Chief Executive Officer of Novan, who will be joined by additional members of the Novan m

Yahoo | February 15, 2022

TBJ reveals 2022 Women in Business Lifetime Achievement Award winner

A longtime life sciences industry executive has been named Triangle Business Journal’s 2022 Women in Business Lifetime Achievement Award winner.

Yahoo | February 10, 2022

Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference

DURHAM, N.C., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that data from the Company’s completed Phase 2 and Phase 3 clinical studies of berdazimer 10.3% gel (previously referred to as SB206) for molluscum contagiosum will be presented at the 2022 Winter Clinical Dermatology Conference, being held January 14-19, 2022, in Koloa, Hawaii. Berdazimer 10.3% gel, containing new chemical entity berdazimer (sodium), is in late-stage developmen

Yahoo | January 14, 2022

Advisors' Inner Circle Fund III Buys Petroleo Brasileiro SA Petrobras, Gazprom PJSC, Roche ...

Investment company Advisors' Inner Circle Fund III (Current Portfolio) buys Petroleo Brasileiro SA Petrobras, Gazprom PJSC, Roche Holding AG, Philip Morris International Inc, Royal Bank of Canada, sells TotalEnergies SE, Rio Tinto PLC, Itau Unibanco Holding SA, China Overseas Land & Investment, CLP Holdings during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Advisors' Inner Circle Fund III.

Yahoo | December 28, 2021

Principal International Multi-Factor ETF Buys Dassault Systemes SE, Universal Music Group NV, ...

Investment company Principal International Multi-Factor ETF (Current Portfolio) buys Dassault Systemes SE, Universal Music Group NV, Lightspeed Commerce Inc, DNB Bank ASA, DNB Bank ASA, sells Nestle SA, Roche Holding AG, ASML Holding NV, Novartis AG, Novo Nordisk A/S during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Principal International Multi-Factor ETF.

Yahoo | December 14, 2021

DWS CROCI(R) International VIP Buys Roche Holding AG, Novartis AG, Tokyo Electron, Sells Novo ...

Investment company DWS CROCI(R) International VIP (Current Portfolio) buys Roche Holding AG, Novartis AG, Tokyo Electron, Sanofi SA, CRH PLC, sells Novo Nordisk A/S, UCB SA, Ono Pharmaceutical Co, Toyota Motor Corp, Shionogi during the 3-months ended 2021Q3, according to the most recent filings of the investment company, DWS CROCI(R) International VIP.

Yahoo | December 13, 2021

ON BlackRock Advantage International Equity Portfolio Buys L'Oreal SA, SAP SE, Novartis AG, ...

Investment company ON BlackRock Advantage International Equity Portfolio (Current Portfolio) buys L'Oreal SA, SAP SE, Novartis AG, Koninklijke Ahold Delhaize NV, Terumo Corp, sells Keyence Corp, Telefonaktiebolaget L M Ericsson, Commonwealth Bank of Australia, Aristocrat Leisure, Prosus NV during the 3-months ended 2021Q3, according to the most recent filings of the investment company, ON BlackRock Advantage International Equity Portfolio.

Yahoo | December 13, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6695 seconds.